Elanco Animal Health (ELAN) Total Debt Growth (3y) (2021 - 2026)
Elanco Animal Health (ELAN) Total Debt Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.05 Bn | 43.08 Bn | - | 15.43% |
| 2 | Teva Pharmaceutical Industries | 43.39 Bn | 39.74 Bn | 2.15 Bn | -7.08% |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 11.33% |
| 4 | Takeda Pharmaceutical | 28.78 Bn | 22.99 Bn | 5.10 Bn | -3.67% |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | -10.43% |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.92 Bn | 11.39 Bn | 798.00 Mn | -13.72% |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 9.99 Bn | - | 92.83% |
| 10 | Alkermes | 8.17 Bn | 7.51 Bn | 397.90 Mn | 72.66% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -13.72% |
| Mar 31, 2026 | -14.15% |
| Dec 31, 2025 | -13.05% |
| Sep 30, 2025 | -13.86% |
| Jun 30, 2025 | -11.46% |
| Mar 31, 2025 | -10.81% |
| Dec 31, 2024 | -13.22% |
| Sep 30, 2024 | -11.71% |
| Jun 30, 2024 | -11.99% |
| Mar 31, 2024 | -5.20% |
| Dec 31, 2023 | -4.54% |
| Sep 30, 2023 | 1.82% |
| Jun 30, 2023 | 43.14% |
| Mar 31, 2023 | 42.34% |
| Dec 31, 2022 | 35.32% |
| Sep 30, 2022 | 323.46% |
| Jun 30, 2022 | 313.27% |
| Mar 31, 2022 | 35.95% |
| Dec 31, 2021 | 38.28% |
| Sep 30, 2021 | 115.96% |